A prospective observational study investigating blood pressure lowering ability and safety of esaxerenone in resistant hypertensive patients by add-on or by replacement from spironolactone or eplerenone
Latest Information Update: 08 Jun 2021
At a glance
- Drugs Esaxerenone (Primary) ; Eplerenone; Spironolactone
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- 08 Jun 2021 New trial record
- 14 Apr 2021 Results presented at the Joint Meeting of the European Society of Hypertension and International Society of Hypertension